You Searched For "Zydus Lifesciences market value" and got 15 results
Sort By:
Zydus Lifesciences acquires UK-based LiqMeds Group for GBP 68 million
LiqMeds Group of companies specialises in the development, manufacturing and supply of oral liq…
PTI
Zydus Lifesciences Q1 2023-24 profit up 2-fold at Rs 1,087 cr
Revenue from operations during the quarter under review stood at Rs 5,139.6 crore as against Rs…
PTI
These are the companies that are making Remdesivir in India
Dr Reddy’s Lab is the sixth pharmaceutical company to introduce Remdesiv…
Zydus Q4 net profit surges 4-fold to ₹1,182 cr; revenue at ₹5,534 cr
Revenue from operations rose to Rs 5,534 crore in the period under review from Rs 5,011 crore i…
PTI
These are the companies that are making Remdesivir in India
Zydus Cadila has launched Remdesivir under the brand name Remdac, used to treat patients sufferin…
Greenwich LifeSciences rockets 2,941% in a single day after encouraging phase 2 data on breast cancer treatment
Greenwich LifeSciences went public in September at an IPO price of $5.75, raising the firm $7.25 mi…
Matthew Fox
Supriya Lifescience IPO: Here’s how you can check the allotment status
The Mumbai-based active pharmaceuticals ingredients (APIs) manufacturer, Supriya Lifescience, is li…
Yes Bank sells over 16 lakh shares of Reliance Capital
New Delhi, Nov 25 () Yes Bank on Monday sold over 16 lakh shares of Reliance Capital for around Rs …
PTI
Cipla to sell anti-viral drug remdesivir as Cipremi in India
In May, US drug maker Gilead Sciences extended a voluntary non-exclusive license to Cipla to man…
Supriya Lifescience beats IPO investors expectations and debuts with 55% premium
The Mumbai-based active pharmaceutical ingredients (APIs) manufacturer, Supriya Lifescience made a …
Zydus Cadila gets USFDA nod to market ointment for treating skin conditions
The company has received final approval from the United States Food and Drug Administration (USFDA…
PTI
Analysts suggest subscribing to this pharma company IPO on discounted valuation and strong product portfolio than peers
Amid myriad initial public offerings (IPO) going on, here is another one worth giving attention to,…
Zydus Cadila gets USFDA nod to market cream for treating skin conditions
The final approval from the United States Food and Drug Administration (USFDA) is to market Fluoci…
PTI
Zydus Cadila launches affordable oral anti-diabetic tablets in India as drug goes off patent
New Delhi, Dec 11 () Drug firm Zydus Cadila on Wednesday said it has launched its affordable oral a…
PTI
Zydus Cadila gets final nod from USFDA to market generic seizures drug
The company has received final approval from the United States Food and Drug Administration (USFDA…